Legend Biotech (LEGN) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Legend Biotech Corporation held its annual general meeting on October 21, 2024, where shareholders approved key resolutions, including the re-election of directors and an increase in shares for their 2020 Restricted Shares Plan. The meeting witnessed robust participation with over 95% of shares represented, underscoring strong shareholder engagement. These decisions highlight ongoing confidence in Legend Biotech’s strategic direction.
For further insights into LEGN stock, check out TipRanks’ Stock Analysis page.
